Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

COVID-19 biomarkers and their overlap with comorbidities in a disease biomarker data model

27 Apr 2021

Abstract excerpt

In response to the COVID-19 outbreak, scientists and medical researchers are capturing a wide range of host responses, symptoms and lingering postrecovery problems within the human population. These variable clinical manifestations suggest differences in influential factors, such as innate and adaptive host immunity, existing or underlying health conditions, comorbidities, genetics and other factors-compounding...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to COVID-19 Clinical Research Studies
Share to Long-Term Effects of COVID-19
Share to SARS-CoV-2 and COVID-19 Research

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34015823
DOI: 10.1093/bib/bbab191

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 24 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

COVID-19 biomarkers and their overlap with comorbidities in a disease biomarker data modelPMID 34015823Read ↗

COVID-19 Biomarkers in research: Extension of the OncoMX cancer biomarker data model to capture biomarker data from other diseasesSemantic proximity Read ↗

Inflammation Patterns in Omicron Variant-Linked COVID-19: Assessing Biomarkers for Predicting Disease SeveritySemantic proximity Read ↗

Identification of Robust Protein Associations With COVID-19 Disease Based on Five Clinical StudiesSemantic proximity Read ↗

Insight into risk associated phenotypes behind COVID-19 from phenotype genome-wide association studiesSemantic proximity Read ↗

Circulating proteins to predict adverse COVID-19 outcomesSemantic proximity Read ↗

Correlating COVID-19 severity with biomarker profiles and patient prognosisSemantic proximity Read ↗

Large-scale Multi-omic Analysis of COVID-19 SeveritySemantic proximity Read ↗

Employing a systematic approach to biobanking and analyzing clinical and genetic data for advancing COVID-19 research.Semantic proximity Read ↗

A time-resolved proteomic and diagnostic map characterizes COVID-19 disease progression and predicts outcomeSemantic proximity Read ↗

Redefining COVID-19 Severity and Prognosis: The Role of Clinical and Immunobiotypes.Semantic proximity Read ↗

Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19Semantic proximity Read ↗

The COVIDome Explorer researcher portalSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.